The global Blood Group Typing Market has entered a period of accelerated growth as hospitals, diagnostic labs, and blood banks shift toward advanced, high-throughput typing technologies. According to new industry insights, the Blood Group Typing Market reached USD 2.26 billion in 2023 and is projected to hit USD 4.82 billion by 2032, expanding at a CAGR of 8.80% from 2024 to 2032. This rise is supported by increased blood donations, expanding transplant procedures, and the rapid adoption of automated analyzers across healthcare systems worldwide.
A key factor strengthening the Blood Group Typing Market is the growing emphasis on transfusion safety. Global health systems are experiencing a surge in surgical procedures and trauma cases, increasing the demand for reliable, fast blood compatibility testing. Modern analyzers developed by leading companies are now capable of minimizing human errors, processing high sample volumes, and providing improved accuracy using gel cards, AI-enabled systems, and molecular typing solutions. These advancements are expected to drive continued adoption in the Blood Group Typing Market over the coming years.
Another essential trend shaping market expansion is the movement toward molecular blood typing and next-generation sequencing. These high-precision technologies are especially valuable for complex antibody cases, prenatal testing, and rare blood group profiling. As healthcare providers seek more sophisticated solutions, molecular platforms are becoming a central growth pillar for the Blood Group Typing Market, enabling improved patient outcomes and enhanced transfusion compatibility.
Get Free Sample Report @ https://www.snsinsider.com/sample-request/2942
The consumables segment continues to hold the largest revenue share, accounting for nearly half of the entire Blood Group Typing Market. The increasing use of reagents, gel cards, and testing kits is linked to the rising volume of blood donations, mass screening programs, and growing hospital needs. Companies such as Grifols and Bio-Rad have introduced next-generation consumables that support high precision and fast turnaround times, further boosting the segment’s dominance in the global Blood Group Typing Market.
Assay-based techniques remain another major contributor to revenue. Their popularity stems from their accuracy, ease of integration into automated systems, and ability to process large batches of samples. Blood banks and medical centers heavily rely on microplate assays and gel column agglutination methods for routine operations. As automation becomes more widespread, these technologies will remain central to the growth trajectory of the Blood Group Typing Market.
ABO blood tests also continue to be fundamental due to their essential role in transfusions, organ transplantation, and emergency care. As demand increases for rapid screening solutions, modern ABO analyzers equipped with AI-driven interpretation tools are gaining traction in the Blood Group Typing Market. Their expanding use across diagnostic labs and emergency care units positions this segment for sustained growth through 2032.
North America currently leads the global Blood Group Typing Market, supported by high donation rates, strong healthcare infrastructure, and regulatory emphasis on blood safety. Automated analyzers are increasingly utilized across hospitals and blood banks, ensuring precise and efficient blood typing. Continuous technological innovation in the region supports strong future growth within the Blood Group Typing Market.
Asia Pacific is emerging as one of the fastest-growing regions, propelled by rising awareness of voluntary blood donation, growing healthcare investments, and expanding adoption of molecular blood typing systems. China and India, in particular, are witnessing significant advancements as government campaigns promote safe transfusion practices. As adoption of automated platforms increases, the region’s contribution to the Blood Group Typing Market is expected to rise steadily through 2032.
The competitive landscape consists of companies leading advancements in AI automation, gel card technology, and molecular assays. Key players include Grifols, Bio-Rad Laboratories, Immucor, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Siemens Healthineers, Danaher, Roche Diagnostics, and Abbott. Their innovations continue to shape the future of the Blood Group Typing Market, supporting improved efficiency, accuracy, and reliability in transfusion medicine.
Other Trending Reports
Kidney Stone Management Market
Ultrasound Equipment Market Growth
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Rohan Jadhav – Principal Consultant
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: [email protected]
